Literature DB >> 20687505

Ligase IV syndrome.

Dimitry A Chistiakov1.   

Abstract

Ligase IV (LIG4) syndrome belongs to the group of hereditary disorders associated with impaired DNA damage response mechanisms. Clinically and morphologically, patients affected with this syndrome are characterized by microcephaly, unusual facial features, growth retardation, developmental delay, skin anomalies and are typically pancytopenic. The disease leads to acute radiosensitivity, immunodeficiency and bone marrow abnormalities. LIG4 syndrome arises from hypomorphic mutations in the LIG4 gene encoding DNA ligase IV; a component of the nonhomologous end-joining machinery, which represents a major mechanism of repair of double strand DNA breaks in mammals. The hypomorphic mutations do not completely abolish but significantly reduce enzyme function. This results in impaired V(D)J recombination, the essential rejoining process in T- and B-cell development, in whose ligase IV plays the key role. As a consequence, patients with LIG4 syndrome frequently develop multiple immune abnormalities, clinically overlapping with severe combined immunodeficiency syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20687505     DOI: 10.1007/978-1-4419-6448-9_16

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  16 in total

1.  Association of LIG4 and XRCC4 gene polymorphisms with the risk of human glioma in a Chinese population.

Authors:  Youle Su; Songtao Qi; Changwu Dou; Lian Shuang; Haicheng Yan
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 2.  Repair of double-strand breaks by end joining.

Authors:  Kishore K Chiruvella; Zhuobin Liang; Thomas E Wilson
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

3.  Yeast DNA ligase IV mutations reveal a nonhomologous end joining function of BRCT1 distinct from XRCC4/Lif1 binding.

Authors:  Kishore K Chiruvella; Brian M Renard; Shanda R Birkeland; Sham Sunder; Zhuobin Liang; Thomas E Wilson
Journal:  DNA Repair (Amst)       Date:  2014-12

Review 4.  DNA Damage and Associated DNA Repair Defects in Disease and Premature Aging.

Authors:  Vinod Tiwari; David M Wilson
Journal:  Am J Hum Genet       Date:  2019-08-01       Impact factor: 11.025

5.  Structural basis of DNA ligase IV-Artemis interaction in nonhomologous end-joining.

Authors:  Pablo De Ioannes; Shruti Malu; Patricia Cortes; Aneel K Aggarwal
Journal:  Cell Rep       Date:  2012-12-07       Impact factor: 9.423

6.  Human LIGIV is synthetically lethal with the loss of Rad54B-dependent recombination and is required for certain chromosome fusion events induced by telomere dysfunction.

Authors:  Sehyun Oh; Yongbao Wang; Jacob Zimbric; Eric A Hendrickson
Journal:  Nucleic Acids Res       Date:  2012-12-28       Impact factor: 16.971

7.  Saccharomyces cerevisiae DNA ligase IV supports imprecise end joining independently of its catalytic activity.

Authors:  Kishore K Chiruvella; Zhuobin Liang; Shanda R Birkeland; Venkatesha Basrur; Thomas E Wilson
Journal:  PLoS Genet       Date:  2013-06-27       Impact factor: 5.917

8.  A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome.

Authors:  Bari J Ballew; Vijai Joseph; Saurav De; Grzegorz Sarek; Jean-Baptiste Vannier; Travis Stracker; Kasmintan A Schrader; Trudy N Small; Richard O'Reilly; Chris Manschreck; Megan M Harlan Fleischut; Liying Zhang; John Sullivan; Kelly Stratton; Meredith Yeager; Kevin Jacobs; Neelam Giri; Blanche P Alter; Joseph Boland; Laurie Burdett; Kenneth Offit; Simon J Boulton; Sharon A Savage; John H J Petrini
Journal:  PLoS Genet       Date:  2013-08-29       Impact factor: 5.917

9.  Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis.

Authors:  Amanda J Walne; Laura Collopy; Shirleny Cardoso; Alicia Ellison; Vincent Plagnol; Canan Albayrak; Davut Albayrak; Sara Sebnem Kilic; Turkan Patıroglu; Haluk Akar; Keith Godfrey; Tina Carter; Makia Marafie; Ajay Vora; Mikael Sundin; Thomas Vulliamy; Hemanth Tummala; Inderjeet Dokal
Journal:  Haematologica       Date:  2016-09-09       Impact factor: 9.941

10.  PDK1 regulates VDJ recombination, cell-cycle exit and survival during B-cell development.

Authors:  Ram K C Venigalla; Victoria A McGuire; Rosemary Clarke; Janet C Patterson-Kane; Ayaz Najafov; Rachel Toth; Pierre C McCarthy; Frederick Simeons; Laste Stojanovski; J Simon C Arthur
Journal:  EMBO J       Date:  2013-03-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.